Stephanie Pappas has a diverse background in Proteomics, Genomics and Wildlife Conservation. In Recent years her focus has been in Cell and Gene Therapies, with primary applications in single cell analysis and sorting, and immunoassay detection. She is highly motivated by scientific technologies that can improve human health conditions and dedicated to protecting ecosystems. During her career in Genomics, Proteomics and Chemistry, she has launched numerous new technologies that have revolutionized the discovery diagnosis and cure of diseases. For years, Stephanie has worked with Key Opinion Leaders (KOL’s) and scientist to find solutions to move their researcher projects forward faster and more efficiently. Most recent applications focused on Lentivirus vector, V1,2,3, capsid empty full and Adeno-associated virus (AAV).As science merges into a new era of regenerative medicine and cell and genetic engineering new hope and treatments are on the horizon for individuals suffering from genetic and degenerative diseases. Studying the underlying mechanisms of disease is extremely challenging! Research science finds itself in a paradigm shift where we will no longer just treat symptoms but focus on helping the body to repair itself from within. Stephanie is as passionate about science, as she is about protecting wildlife. She strongly believes that saving a species is dependent on habitat restoration and protection of the ecosystem in which a species live. It's a daunting task which requires collaboration between many stakeholders working in harmony for a common goal. As a business professional, Stephanie is highly motivated by innovated technologies and habitat restoration programs. She has achieved Presidents Club several times during her career, and been recognized for her conservation efforts. She thrives in dynamic corporate environments.